Thus, LRRK2 interacts with many key proteins that are implicated in PD, suggesting its pivotal role, even in the pathogenesis of sporadic PD, and offering a new potential target for disease-modifying approaches. This evidence concerns the gene LRRK2 and Parkinson disease.